Published in Clin Orthop Relat Res on March 01, 1986
Giant cell tumor of bone: a neoplasm or a reactive condition? Int J Clin Exp Pathol (2008) 1.26
Human giant cell tumors of bone identification and characterization of cell types. J Clin Invest (1987) 1.24
Gene expression of transforming growth factor-beta 1 and its type II receptor in giant cell tumors of bone. Possible involvement in osteoclast-like cell migration. Am J Pathol (1994) 1.02
Modern interpretation of giant cell tumor of bone: predominantly osteoclastogenic stromal tumor. Clin Orthop Surg (2012) 1.00
Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts. Am J Pathol (1997) 0.99
Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. PLoS One (2013) 0.90
Collagenase expression and activity in the stromal cells from giant cell tumour of bone. Bone (2009) 0.89
Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction. J Clin Invest (1995) 0.87
Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation. PLoS One (2012) 0.84
Local control of giant cell tumors of the long bone after aggressive curettage with and without bone cement. BMC Musculoskelet Disord (2014) 0.84
Low content of estrogen receptors in human giant cell tumors of bone. Arch Orthop Trauma Surg (1994) 0.82
p63 regulates cell proliferation and cell cycle progression‑associated genes in stromal cells of giant cell tumor of the bone. Int J Oncol (2012) 0.81
Regulation of MMP-9 (92 kDa type IV collagenase/gelatinase B) expression in stromal cells of human giant cell tumor of bone. Clin Exp Metastasis (1997) 0.80
Enrichment of c-Met+ tumorigenic stromal cells of giant cell tumor of bone and targeting by cabozantinib. Cell Death Dis (2014) 0.78
Expressional Analysis of GFP-Tagged Cells in an In Vivo Mouse Model of Giant Cell Tumor of Bone. Open Orthop J (2013) 0.76
Rare Presentation of Giant Cell Tumor in the Internal Auditory Canal: Case Report and Review of the Literature. J Neurol Surg Rep (2015) 0.75
3-Dimensional micropillar drug screening identifies FGFR2-IIIC overexpression as a potential target in metastatic giant cell tumor. Oncotarget (2017) 0.75
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am (1971) 9.93
Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med (1985) 8.16
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA (1999) 7.37
Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. N Engl J Med (1991) 6.09
Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells. Proc Natl Acad Sci U S A (1976) 5.40
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89
Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med (1988) 4.69
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum (1990) 4.39
CCR5 is characteristic of Th1 lymphocytes. Nature (1998) 3.92
Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum (1995) 3.83
Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment. J Bone Joint Surg Am (1998) 3.56
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol (2001) 3.53
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum (2000) 3.51
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest (1986) 3.43
Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells. J Clin Invest (1979) 3.34
A heritable disorder of connective tissue. Hydroxylysine-deficient collagen disease. N Engl J Med (1972) 3.32
Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect (1998) 3.27
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab (1983) 3.27
Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am (1994) 2.93
The response of articular cartilage to mechanical injury. J Bone Joint Surg Am (1982) 2.92
Collagenase production by rheumatoid synovial cells: stimulation by a human lymphocyte factor. Science (1977) 2.91
Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am (1994) 2.86
Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am (1999) 2.85
Concomitant secretion of prourokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med (1984) 2.78
Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol (1998) 2.68
Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis (2000) 2.59
Collagenases in human synovial fluid. J Clin Invest (1969) 2.52
Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am (1986) 2.49
Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells. J Exp Med (1977) 2.47
The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am (1982) 2.46
Studies on collagenase from rheumatoid synovium in tissue culture. J Clin Invest (1968) 2.42
Clonal dominance among T-lymphocyte infiltrates in arthritis. Proc Natl Acad Sci U S A (1988) 2.36
Chondroblastoma of bone. J Bone Joint Surg Am (2000) 2.33
The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol (1997) 2.29
Collagenases (third of three parts). N Engl J Med (1974) 2.28
The synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am (1983) 2.28
Purification of a factor from human blood monocyte-macrophages which stimulates the production of collagenase and prostaglandin E2 by cells cultured from rheumatoid synovial tissues. FEBS Lett (1981) 2.27
An endopeptidase from rheumatoid synovial tissue culture. Biochim Biophys Acta (1972) 2.25
Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am (1988) 2.24
A urine inhibitor of interleukin 1 activity that blocks ligand binding. J Immunol (1987) 2.17
Human collagenase: identification and characterization of an enzyme from rheumatoid synovium in culture. Science (1967) 2.15
Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg Am (1970) 2.15
Contribution of interleukin 17 to synovium matrix destruction in rheumatoid arthritis. Cytokine (2000) 2.11
Osteoarticular allografts for reconstruction in the proximal part of the humerus after excision of a musculoskeletal tumor. J Bone Joint Surg Am (1990) 2.08
Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. J Biol Chem (1989) 2.07
Collagenases (first of three parts). N Engl J Med (1974) 2.06
High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Respir Dis (1992) 2.05
Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis. Am Rev Respir Dis (1989) 1.99
Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol (1998) 1.97
Articular cartilage: tissue design and chondrocyte-matrix interactions. Instr Course Lect (1998) 1.90
Interleukin 1 suppresses expression of cartilage-specific types II and IX collagens and increases types I and III collagens in human chondrocytes. J Clin Invest (1988) 1.89
Purification and characterization of human interleukin-1 beta expressed in recombinant Escherichia coli. Eur J Biochem (1986) 1.89
A human inhibitor of tumor necrosis factor alpha. J Exp Med (1988) 1.85
Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol (1993) 1.84
Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res (2001) 1.83
Fractures about the hip in an institutionalizedpatient population. II. Survival and ability to walk again. J Bone Joint Surg Am (1968) 1.82
Increased prostaglandin production by human monocytes after membrane receptor activation. J Immunol (1979) 1.77
Calcific myonecrosis. A late sequela to compartment syndrome of the leg. Clin Orthop Relat Res (1995) 1.75
Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis (2003) 1.74
Production of cytokines around loosened cemented acetabular components. Analysis with immunohistochemical techniques and in situ hybridization. J Bone Joint Surg Am (1993) 1.73
Articular cartilage repair and transplantation. Arthritis Rheum (1998) 1.73
Influences of gamma interferon on synovial fibroblast-like cells. Ia induction and inhibition of collagen synthesis. J Clin Invest (1985) 1.71
Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol (1984) 1.71
Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). J Clin Invest (1986) 1.70
Interleukin 1 is present in normal human epidermis. J Immunol (1986) 1.70
Collagenase production by human synovial tissues. Ann N Y Acad Sci (1975) 1.70
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest (1995) 1.69
Massive resection and allograft transplantation in the treatment of malignant bone tumors. N Engl J Med (1976) 1.67
Expression cloning of an adenylate cyclase-coupled calcitonin receptor. Science (1991) 1.67
Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. J Clin Invest (1999) 1.67
Desmoplastic fibroma of bone. A report of eight cases and review of the literature. J Bone Joint Surg Am (1985) 1.67
Induction of human interleukin 1 mRNA measured by collagenase- and prostaglandin E2-stimulating activity in rheumatoid synovial cells. Eur J Immunol (1984) 1.66
The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. Clin Orthop Relat Res (1991) 1.66
Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease. Osteoarthritis Cartilage (2009) 1.65
Clinical experience with allograft implantation. The first ten years. Clin Orthop Relat Res (1983) 1.64
Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. Clin Immunol Immunopathol (1989) 1.63
Giant synovial cysts of the calf in patients with rheumatoid arthritis. J Bone Joint Surg Am (1968) 1.62
Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum (1984) 1.62
IFN-gamma and 1,25(OH)2D3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells. J Immunol (1992) 1.62
Preoperative, intraoperative, and postoperative radiation in the treatment of primary soft tissue sarcoma. Cancer (1985) 1.62
Accuracy of CT-guided needle biopsy of musculoskeletal neoplasms. AJR Am J Roentgenol (1998) 1.59
Generation of collagenase-resistant collagen by site-directed mutagenesis of murine pro alpha 1(I) collagen gene. Proc Natl Acad Sci U S A (1990) 1.57
Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am (1990) 1.57
Osteoid osteoma: percutaneous radio-frequency ablation. Radiology (1995) 1.57
Modulation of surface antigens of a human monocyte cell line, U937, during incubation with T lymphocyte-conditioned medium: detection of T4 antigen and its presence on normal blood monocytes. J Immunol (1983) 1.57
Individualizing management of aggressive fibromatoses. Int J Radiat Oncol Biol Phys (1998) 1.56
Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur J Immunol (1997) 1.56
The results of transplantation of intercalary allografts after resection of tumors. A long-term follow-up study. J Bone Joint Surg Am (1997) 1.56
Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell Immunol (1986) 1.53